Latest filing published 08 Jun 2021 for Amphastar Pharmaceuticals, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David Maris is a declared insider of Amphastar Pharmaceuticals, Inc. (board member), with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 8 June 2020 and the latest from 7 June 2021.
The open-market record is one-sided, with 1 purchase worth €17k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants.
The newest entry dates from 8 June 2021: a share grant, in Amphastar Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 2,260 days ago, on 18 August 2020. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration